Agilent Posts 9 Percent Rise in Q4 Revenues as Academic/Government Gloom Continues | GenomeWeb

This story originally ran on Nov. 16.

Agilent this week reported $1.73 billion in Q4 2011 revenues, up 9 percent over $1.58 billion in Q4 2010.

The company's Life Sciences division, which includes its mass spectrometry and proteomics businesses, posted revenues of $471 million, a 9 percent increase over $431 million in the year ago period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.